InforMing the PAthway of COPD Treatment (The IMPACT Study): Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: An Analysis Based on Baseline COPD Medication Use
D. Singh, G. Criner, M. Dransfield, D. Halpin, M. Han, C. E. Jones, S. Kilbride, P. Lange, D. Lomas, F. Martinez, S. Pascoe, R. Wise, David A. Lipson
{"title":"InforMing the PAthway of COPD Treatment (The IMPACT Study): Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: An Analysis Based on Baseline COPD Medication Use","authors":"D. Singh, G. Criner, M. Dransfield, D. Halpin, M. Han, C. E. Jones, S. Kilbride, P. Lange, D. Lomas, F. Martinez, S. Pascoe, R. Wise, David A. Lipson","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1116","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":131398,"journal":{"name":"A24. COPD: THERAPY, IMAGING, AND MOLECULAR MARKERS","volume":"227 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"A24. COPD: THERAPY, IMAGING, AND MOLECULAR MARKERS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1116","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
